Tuesday, 06. January 2009

Life sciences


Advanced genomics and its applications for health



Combating major diseases



Applications-orientated genomic approaches to medical knowledge and technologies



Combating cardiovascular diseases, diabetes, and rare diseases



Combating resistance to antibiotics and other drugs



Studying the brain and combating diseases of the nervous system



Studying human development and the ageing process



Combating cancer



Confronting the major communicable diseases linked to poverty



Specific support actions across thematic priority 1


Policy support

International co-operation

Reporting module


EUR-INTAFAR - INHIBITION OF NEW TARGETS FOR FIGHTING ANTIBIOTIC RESISTANCE (Life sciences, genomics and biotechnology for health) (2005-01-01 - 2009-12-31) (»add to infobox)



ACRONYM:EUR-INTAFAR
BUDGET:15.333.300 €
FUNDING:11.301.800 €
INSTRUMENT:Integrated Project
PROGRAMME:Life sciences, genomics and biotechnology for health
The introduction of antibiotics in the medical practice has drastically reduced illness and death from infectious diseases. However, bacteria have exhibited a remarkable capacity to become resistant to commonly used antibacterial compounds. In parallel to efforts aimed at better understanding the strikingly diverse mechanisms they use, it is important to design strategies which will allow to counteract them and to search for new targets, ideally essential and specific to bacterial physiology. Our approach is based on the well established facts that peptidoglycan biosynthesis and cell morphogenesis are related phenomena and that they are totally specific to bacterial cells, without even remotely equivalent processes in eukaryotic cells. By attempting to interfere with these processes by inhibiting enzyme activities or perturbing protein-protein interactions, one should be able to design new antibacterial compounds active against pathogenic organisms such as streptococci, staphylococci, enterococci or chlamydiae. Five workpackages will provide converging approaches to the same general goal. 1 The study and the design of inhibitors for penicillin-resistant transpeptidases. 2 The development of inhibitors of the glycosyltransferase domain of class A penicillin-binding proteins. 3 The study and the design of inhibitors for the synthesis and transport steps of cell wall subunits located at the plasma membrane. 4 The study and the design of inhibitors for the synthesis of soluble peptidoglycan precursors. 5 The study of cell morphogenesis and of its regulation and the design of compounds which might interfere with these processes. This ambitious project will lead to new insights into bacterial physiology and might have a pronounced impact in other areas including biotechnology, and bacterial pathogenesis. Indeed, this project will create renewed interest in these key areas and pave the way to innovative for fighting resistance to antibiotics.

Keywords:
Antibiotic resistance, new targets, peptidoglycan, drug design, drug chemistry, morphogenesis

COORDINATOR (1/1) 


Jean-Marie FRERE (Contact / UNIVERSITE DE LIEGE (BE332 - Arr. Liège) (BE - Belgium))

PARTICIPANTS (13/13) 


Tanneke DEN BLAAUWEN (Contact / UNIVERSITEIT VAN AMSTERDAM (NL326 - Groot-Amsterdam) (NL - Netherlands))

Didier BLANOT (Contact / UNIVERSITE PARIS-SUD (FR104 - Essonne) (FR - France))

Eefjan BREUKINK (Contact / UNIVERSITEIT UTRECHT (NL310 - Utrecht) (NL - Netherlands))

Waldemar VOLLMER (Contact / EBERHARD-KARLS UNIVERSITAET TUEBINGEN (DE142 - Tübingen, Landkreis) (DE - Germany))

Regine HAKENBECK (Contact / TECHNISCHE UNIVERSITAET KAISERSLAUTERN (DEB32 - Kaiserslautern, Kreisfreie Stadt) (DE - Germany))

Michel ARTHUR (Contact / INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR101 - Paris) (FR - France))

Ian CHOPRA (Contact / UNIVERSITY OF LEEDS (UKE42 - Leeds) (UK - Great Britain))

Jean-Pierre SIMORRE (Contact / COMMISSARIAT A L'ENERGIE ATOMIQUE (CEA) (FR101 - Paris) (FR - France))

Christopher SCHOFIELD (Contact / THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD (UKJ14 - Oxfordshire) (UK - Great Britain))

Yves LE MERRER (Contact / CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR101 - Paris) (FR - France))

Stanislav GOBEC (Contact / FACULTETA ZA FARMACIJO - UNIVERZA V LJUBLJANI (SI00E - Osrednjeslovenska) (SI - Slovenia))

Uros URLEB (Contact / LEK FARMACEVTSKA DRUZBA DD LEK PHAR MACEUTICALS DD SOCIETE PHARMACEUTIQ UE LEK DD (SI00E - Osrednjeslovenska) (SI - Slovenia))

Frédéric MARC (Contact / PROTNETEOMIX (FR511 - Loire-Atlantique) (FR - France))

RELATED THEMATIC AREAS (1/1) 

Combating resistance to antibiotics and other drugs




SEARCH



»Advanced Search



SHORT CUTS

»Thematic areas

»Organisations

»Persons



INFOBOX (0/0) show all
Your infobox is empty


LifeCompetence is operated by AVEDAS.
LifeCompetence operated by AVEDAS
Contact: support@avedas.com


Powered by CONVERIS 2.0